ArisGlobal to Present Session at World Drug Safety Congress 2018 on ‘‘Automation is transforming pharmacovigilance. Is your organization ready?”

Mar 27, 2018

MIAMI, FL.  MARCH 27, 2018 — ArisGlobal, LLC, a global leader in providing cloud-based software solutions for the life sciences, will present at the World Drug Safety Congress Americas 2018 conference to be held in Philadelphia, PA from April 10-11, 2018, on the topic “Automation is transforming pharmacovigilance. Is your organization ready?

Presented by Dr. Vivek Ahuja, Vice President, Global Pharmacovigilance, the presentation, scheduled for April 10, 2:30-2:50 p.m., is part of the conference’s Next Gen Tech Track. Dr. Ahuja will discuss whether artificial intelligence (AI) is more hype than reality, and how an organization can determine if it has the discipline to transform itself, how to find the right opportunities to explore, and then share the steps involved in implementing an AI strategy for pharmacovigilance.

“From being a mere exploratory experiment to giving an exhilarating experience, cognitive computing in pharmacovigilance is now fast evolving. Fairly soon, it will disrupt the way how drug safety departments will fulfill their compliance obligations. Early adopters will establish themselves as change leaders of the world of drug safety. My presentation will provide insight into how Marketing Authorization holders, CROs and even regulatory authorities can benefit from the technology advancements that AI can offer.”

ArisGlobal is an exhibitor and Gold Sponsor of World Drug Safety Congress and will be showcasing LifeSphere® Safety, its cognitive computing pharmacovigilance platform, in Booth #18. Attendees are invited to meet with ArisGlobal staff to learn about its innovative and leading pharmacovigilance and safety platform.


About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn:
Follow @Aris_Global on Twitter:


Erika Thomas
+305-726-6601 |